Our Goals and Objectives
To provide and promote evidence and recommendations for policy makers on methods to increase availability and decrease the consumer price of quality assured artemisinin-based combination therapies through the private sector.
PSI and its partners will achieve this goal through three primary objectives, which are to provide policy makers with evidence and actionable recommendations in the following areas:
- Levels and trends in the availability, price, quality, volume, retailer perceptions, and knowledge of antimalarial drugs at different service delivery points;
- Wholesaler and retailer volumes and the components of the consumer price of antimalarials, as well as current policy influences on the market, and specifically, on mark-ups from import to outlet; and
- Consumer treatment-seeking behavior, and volumes of specific antimalarials
consumed, to support the development and monitoring of policies and other interventions to increase rates of effective malaria treatment.
A crosscutting objective will be to prepare and execute country-specific advocacy plans and international dissemination activities to ensure that the evidence is effectively translated into policy.
Project Design and Implementation
PSI country offices in each of the eight study countries will provide the required capacity foundation for successful project implementation. In addition, these offices can leverage well-established relationships with local government policy makers, and other relevant stakeholders which will facilitate the achievement of project objectives. This strong field presence is a unique advantage of the PSI Team, and will enable us to avoid local project implementation pitfalls likely to beset non-resident organizations.